RECURSION PHARMACEUTICALS, INC.
RXRX
54 insider filings · Latest: Oct 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 18 1:44 PM | Bumpus Namandje | Proposed Sale | 3,963 | $3.18 | $12.6K | — | View → |
| Jun 18, 2026 | Jun 18 1:37 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.18 | $127.2K | — | View → |
| Jun 5, 2026 | Jun 5 9:03 PM | Christopher GibsonDirector | Sale | 40,000 | $3.62 | $144.8K | 883,735(D) | View → |
| Jun 5, 2026 | Jun 5 9:02 PM | Najat KhanDirector, CEO and President | Sale | 23,588 | $3.58 | $84.5K | 2,175,796(D) | View → |
| Jun 5, 2026 | Jun 5 5:29 PM | Najat Khan | Proposed Sale | 23,588 | $3.58 | $84.5K | — | View → |
| Jun 5, 2026 | Jun 5 2:19 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.62 | $144.8K | — | View → |
| Jun 3, 2026 | Jun 4 9:04 PM | Namandje BumpusDirector | Sale | 4,386 | $3.54 | $15.5K | 43,171(D) | View → |
| Jun 2, 2026 | Jun 4 9:04 PM | Blake BorgesonDirector | Sale | 30,000 | $3.68 | $110.4K | 6,169,863(D) | View → |
| Jun 3, 2026 | Jun 3 2:16 PM | Bumpus Namandje | Proposed Sale | 4,386 | $3.54 | $15.5K | — | View → |
| Jun 2, 2026 | Jun 2 3:04 PM | Borgeson Blake | Proposed Sale | 30,000 | $3.68 | $110.4K | — | View → |
| May 22, 2026 | May 27 8:15 PM | Christopher GibsonDirector | Sale | 40,000 | $3.08 | $123.2K | 883,735(D) | View → |
| May 22, 2026 | May 22 2:13 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.08 | $123.2K | — | View → |
| May 7, 2026 | May 8 8:59 PM | Christopher GibsonDirector | Sale | 40,000 | $3.37 | $134.8K | 926,556(D) | View → |
| May 5, 2026 | May 7 8:44 PM | Blake BorgesonDirector | Sale | 30,000 | $3.52 | $105.6K | 6,199,863(D) | View → |
| May 7, 2026 | May 7 3:13 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.37 | $134.8K | — | View → |
| May 5, 2026 | May 5 2:22 PM | Borgeson Blake | Proposed Sale | 30,000 | $3.52 | $105.6K | — | View → |
| Apr 22, 2026 | Apr 24 8:23 PM | Christopher GibsonDirector | Sale | 40,000 | $3.61 | $144.4K | 906,556(D) | View → |
| Apr 22, 2026 | Apr 22 1:47 PM | Gibson Christopher | Proposed Sale | 40,000 | $3.61 | $144.4K | — | View → |
| Apr 7, 2026 | Apr 8 8:58 PM | Christopher GibsonDirector | Sale | 40,000 | $3.10 | $124.0K | 906,556(D) | View → |
| Apr 7, 2026 | Apr 8 8:58 PM | Blake BorgesonDirector | Sale | 30,000 | $3.10 | $93.0K | 6,229,863(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Oct 7 10:08 PM | Robert HershbergDirector | Option Exercise | 25,000 | $2.22 | 500,000(D) | View → |
| Jun 5, 2026 | Jun 5 9:03 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,263,334(D) | View → |
| May 22, 2026 | May 27 8:15 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,303,334(D) | View → |
| May 7, 2026 | May 8 8:59 PM | Christopher GibsonDirector | Conversion | 60,000 | — | 4,343,334(D) | View → |
| Apr 22, 2026 | Apr 24 8:23 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,403,334(D) | View → |
| Apr 7, 2026 | Apr 8 8:58 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,443,334(D) | View → |
| Mar 23, 2026 | Mar 25 8:36 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,483,334(D) | View → |
| Mar 9, 2026 | Mar 11 9:41 PM | Christopher GibsonDirector | Conversion | 20,000 | — | 4,523,334(D) | View → |
| Feb 19, 2026 | Feb 20 12:30 AM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,543,334(D) | View → |
| Feb 4, 2026 | Feb 6 10:53 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,583,334(D) | View → |
| Jan 20, 2026 | Jan 23 12:34 AM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,623,334(D) | View → |